Prothena (PRTA) said Friday its board has approved a share repurchase plan of up to $100 million through Dec. 31, 2026.
The company said it plans to buy back shares from time to time through various means, subject to prevailing market conditions, corporate and regulatory limitations, and other factors and that the program can be terminated at any time.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.